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Among the variables that characterize mechanical
cardiac performance, left ventricular ejection fraction
(LVEF) has attracted broad clinical interest, as
various studies have provided ample evidence that
LVEF is a major prognostic parameter [1–4]. Also,
LVEF is among the selection criteria for device-based
anti-arrhythmic or resynchronization therapy [5, 6].
Several imaging techniques allow for the assessment
of LVEF, e.g., 2D and 3D echocardiography, gated
SPECT, contrast angiography, cardiovascular mag-
netic resonance imaging (CMR) and computed
tomography [7]). In patients with suspected ischemia,
a common strategic sequence in which imaging
techniques are being utilized is echocardiography,
gated SPECT and coronary angiography, the latter
frequently combined with or followed by intervention.
As these three imaging techniques may all yield
LVEF values it is not uncommon in clinical practice
to have access to multiple LVEF measurements of the
same patient.
If, in one patient, these three LVEF values are
available, what would be the measure of preference?
The answer to this question depends upon the
reliability of the measurement technique and on its
proven prognostic value. Whether or not the echo-
cardiogram, gated SPECT and the ventriculogram
determined during angiography faithfully assess
LVEF depends on a large variety of factors: the
build of the patient, the technical quality of the
equipment, amount of views (monoplane/biplane),
quality of the analyzing software/algorithms, the
potential for quantitative analysis, and of the opera-
tor/analyst being the most important ones [8–13].
Comparison with CMR, an important reference
technique often being considered as a gold standard
[14–19], can help in getting an impression of
the relative accuracy of LVEF as measured by
echocardiography, gated SPECT and contrast ven-
triculography [20–22].
– Jenkins et al. [23] compared serial LVEF values
from 2D biplane and 3D echocardiography with
serial MRI measurements in patients with prior
myocardial infarction. They found that LVEF
values measured with 2D and 3D echocardiogra-
phy correlated significantly with MRI; r = 61%
and 86% for baseline, and 70% and 82% for
follow-up, respectively. However, when a com-
parison is made of the serial changes in LVEF,
only 3D echocardiography correlated signifi-
cantly with MRI (r = 58%).
– In a review article, Sciagra` [24] cites 21 studies in
which SPECT- and CMR-determined LVEF val-
ues were compared. Correlations measured in
these studies ranged between 70 and 94%; 5
studies report correlations between 70 and 79%,
11 between 80 and 89% and 5 above 90%.
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– Several studies compared contrast monoplane or
biplane ventriculography with CMR [25–28].
Correlation coefficients in these studies ranged
from 72% to 98%.
When realizing that correlations of, e.g., 80 and
86%, roughly stand for 2/3 and 3/4 explained variance,
respectively, echocardiography, gated SPECT and
contrast ventriculography may yield LVEF values that
differ considerably from CMR despite the statistical
significance of the linear relationship. However, CMR
is not suitable for large scale application in the context
of the regular clinical diagnostic procedures for the
evaluation of patients with suspected or known
ischemic heart disease. Hence, in clinical practice, a
certain (considerable?) amount of LVEF imprecision
or uncertainty is inevitable.
Mutual comparison of LVEF determined by
echocardiography, gated SPECT and contrast ven-
triculography demonstrates that these measurements
contain to a certain extent different information and/
or noise: correlations of 72–75% in 2D biplane
echocardiography versus gated SPECT [29, 30], 93%
in 3D echocardiography versus gated SPECT [31],
49–93% in 2D biplane echocardiography versus
ventriculography [12, 32, 33], 80% between 3D
echocardiography and ventriculography [34] and 69–
87% for gated SPECT versus contrast left ventricu-
lography [32, 35–37] were reported. Hence,
potentially, one measurement could bear other diag-
nostic and prognostic information than the other.
It is the merit of Gimelli et al. [38] to have
compared the prognostic value of LVEF determined
by echocardiography (single plane), gated SPECT
and contrast ventriculography (single plane). The
authors found, in a large population of patients with
known or suspected ischemic heart disease, a superior
predictive value of gated SPECT (resting, not post-
exercise) LVEF. What can explain this finding? It is
well known that systematic differences exist because
SPECT may exclude part of the outflow tract [36].
Also, it may well be that the single plane LVEF
measurements in the echocardiograms and in the
contrast ventriculograms could not compete with the
tomographic gated SPECT technique. Finally, the
SPECT LVEF calculation is more objective and
reproducible due to automated analysis [39].
Gimelli et al. studied a large group of 422 patients
with for the larger part an adequate cardiac function.
Ejection fractions below, but also above 50%, the
lower limit of normal in male subjects, are repre-
sented in the study group. Possibly (this was not
made explicit in their publication), part of the patients
had symptoms of overt, stage C, heart failure, but
most of the other patients in the study group can be
characterized as stage B heart failure (patients with
structural heart disease, at risk for heart failure but
still without symptoms of this disease [40]), several
of them with asymptomatic LV systolic dysfunction
and angina pectoris/myocardial infarction.
In a review article [41], Goldberg and Jessup state
that the number of stage B heart failure patients with
LV systolic dysfunction is four times greater than the
number of patients who are in stages C (structural
heart disease with prior or current symptoms of heart
failure) and D (refractory heart failure requiring
specialized interventions) combined. Coronary artery
disease is the prevailing etiology of asymptomatic LV
systolic dysfunction. In the Framingham study, half of
the subjects with asymptomatic LV systolic dysfunc-
tion at entry had a previous myocardial infarction
versus 2% of the subjects with a normal LV function
at entry [42]. The prognosis of asymptomatic LV
systolic dysfunction was unfavorable: 26% developed
overt heart failure after 5 years of follow-up, and 40%
died (compared to 12% of the subjects with a normal
baseline left-ventricular function). The median sur-
vival for subjects with asymptomatic LV systolic
dysfunction was only 7.1 years. Similarly alarming
numbers were provided by the ECHOES (Echocar-
diographic Heart of England Screening) study [43],
reporting a 69% five-year survival for asymptomatic
LV systolic dysfunction (compared to 93% for the
general population, 62% for subjects with heart failure
but without LV systolic dysfunction, and 53% for
subjects with heart failure and LV systolic
dysfunction).
No specific treatment is currently available for
patients with asymptomatic LV systolic dysfunction.
However, a recent AHA Scientific Statement [44]
mentions this group of patients as a main target for
further study, because LV systolic dysfunction is the
first step in the remodeling process that finally leads
to overt heart failure. Research recommendation 4
reads: ‘‘Develop appropriate studies to identify and
eventually treat asymptomatic individuals with LV
dysfunction (stage B) and to prevent its
development.’’
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Most likely, the findings of Gimelli et al. reflect
partly the prognosis of stage B heart failure patients.
Therefore, it could be worthwhile to carefully monitor
patients for cardiac remodeling, possibly by repeated
3D echocardiography [23, 45], after they have been
identified as asymptomatic LV systolic dysfunction
patients by gated SPECT (of which Gimelli et al.
demonstrated prognostic value additional to clinical
variables) or, possibly, by a reliable biplane echocar-
diogram or ventriculogram or by a 3D echocardiogram.
A similar study as that by Gimelli et al., in which, in
this setting, the prognostic power additional to clinical
variables of LVEF determined by gated SPECT is
compared with LVEF determined by biplane echocar-
diography or contrast ventriculography or by 3D
echocardiography would be a logical next step.
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